Menopause Treatment Access, Forever Chemicals and Breast Cancer Risk, and New Vaccines for the Ebola Outbreak
Trial status and details compiled from ClinicalTrials.gov. Results and topline data drawn from sponsor releases or publications, where applicable. Regulatory information drawn from the FDA. Research accurate as of November 9, 2026. The FDA has approved updated labeling on boxed warnings for three menopausal hormone therapy products and is exploring the possibility of vaginal estrogen … Read more
Women’s Health Advances: A New NIH Division And Menopause-Stage Obesity Data
Trial status and details compiled from ClinicalTrials.gov. Results and topline data drawn from sponsor releases or publications, where applicable. Regulatory information drawn from the FDA. Research accurate as of 24/10/2026. Over the last couple of weeks, there have been several developments in women’s health and metabolic medicine, spanning research, policy, and regulatory landscapes. An executive … Read more
Rethinking Diabetes and Obesity Care: EASD 2026 and New WHO Guidelines
Trial status and details compiled from ClinicalTrials.gov. Results and topline data drawn from sponsor releases or publications, where applicable. Regulatory information drawn from the FDA. Research accurate as of: 10/10/2026 The 62nd EASD annual meeting featured the latest research and updated recommendations for type 2 diabetes care, which broaden the focus from managing glucose levels … Read more
Clinical Trials Roundup: Changing The Path To Clinical Development
Trial status and details compiled from ClinicalTrials.gov. Results and topline data drawn from sponsor releases or publications, where applicable. Regulatory information drawn from the FDA. Research accurate as of: 26 September 2026 Several recent developments show a change in the clinical development landscape, from changes in regulatory pathways for moving new drugs into first-in-human trials … Read more
New Developments in Obesity, Type 1 Diabetes, and Women’s Health
Trial status and details compiled from ClinicalTrials.gov. Results and topline data drawn from sponsor releases or publications, where applicable. Regulatory information drawn from the FDA. Research accurate as of: 14 September 2026 Over the past couple of weeks, there have been several notable clinical trial developments including a new Phase 3 trial evaluating orforglipron (an … Read more